Latest News and Press Releases
Want to stay updated on the latest news?
-
Gyre Therapeutics Announces China’s NMPA Approval of Avatrombopag Maleate Tablets for the Treatment of CLD-Associated Thrombocytopenia
-
Gyre Therapeutics Announces Publication in Journal of Gastroenterology and Hepatology
-
Gyre Pharmaceuticals Receives IND Approval from China’s NMPA to Evaluate F230 for the Treatment of Pulmonary Arterial Hypertension
-
Gyre Therapeutics Announces Expected Addition to the Russell 2000® and Russell 3000® Indexes
-
Gyre Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
-
Gyre Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
-
Gyre Therapeutics Expands Board of Directors with Appointment of Rodney L. Nussbaum
-
Gyre Therapeutics Presents Poster at the American Association for the Study of Liver Diseases (AASLD) Annual Liver Meeting